GeoVax Reports 2021 Year-End Financial Results and Provides

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Related Keywords

Delaware , United States , Australia , Sudan , David Dodd , Malaria Vaccine Development Program , National Cancer Institute , Emory University , Us Department Of Defense Do , Drug Administration , Nasdaq , United States Agency For International Development , Exchange Commission , Geovax Labs Inc , Therapeutics Inc , Us Army , Leidos Inc , Products Clinical Trials Grants Program , Burnet Institute , Stanford University , Advancing Phase , Vax Labs , Standard Time , Trials Underway , Immunocompromised Patients , Booster Vaccine , Enabling Activities Progressing , Japan Coronavirus Vaccine , Trial Underway , Advanced Head , Gene Directed Enzyme Prodrug Therapy , Orphan Products Clinical Trials Grants , Immune Checkpoint Inhibitor , Fever Virus Vaccines , United States Agency , International Development , Antibody Dependent Enhancement , Lassa Fever , Annual Report , Geovax Labs , Zika Virus , Consolidated Statements , Coronavirus Pandemic , Technology , Science , Business , Health , Infectious Diseases , Newmediawire , Cancer , Clinical Trials , Ebola Virus , Biotechnology ,